LRP1 and Alzheimer disease: Also, Kim et al. showed that MAFLD accelerates the sign of Alzheimer’s disease (AD) in central nervous system (CNS) by inducing neuronal apoptosis and decreased expression of lipoprotein receptor 1 (LRP1) which is responsible for beta amyloid plaque clearance in AD [7].